BiOptic (ROCO:6850) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


ROCO:6850 BiOptic Inc ROCO:6850
92 GF Score
Price NT$34.40
GF Value NT$44.89
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is BiOptic Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

BiOptic's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

ROCO:6850 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, BiOptic's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BiOptic Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BiOptic's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where BiOptic's Margin of Safety % (DCF Earnings Based) falls into.


ROCO:6850
92GF Score
BiOptic Inc ROCO:6850
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BiOptic (ROCO:6850) Overvalued in 2026?

Based on GuruFocus' analysis, BiOptic stock appears to be undervalued. The current stock price of NT$34.40 is trading 23.4% below its estimated GF Value™ of NT$44.89. GuruFocus considers BiOptic to be Modestly Undervalued.

Key valuation signals for ROCO:6850:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: NT$44.89 vs. price of NT$34.40 (23.4% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6850 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BiOptic Business Description

Address No. 108-3, Minquan Road, 4th Floor, Xindian District, New Taipei, TWN, 23141
BiOptic Inc is a biotechnology instrumentation company that develops scientific products for research and clinical applications. It serves professionals and laboratories dedicated to life science research, clinical diagnostics, pharmaceutical and food industries, animal husbandry, and agriculture, performing diagnostic molecular genetic analyses.
92GF Score

Get the complete analysis for ROCO:6850

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$34.40
Price
NT$44.89
GF Value